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PP20.
Early Commercialization Experience with New Long Term Vascular
Access for Catheter-Dependent Patients
Howard E Katzman. University of Miami Hospital, Miami, FL
Objectives: The purpose of this abstract is to report early commercial-
ization experience with the HeRO™ Vascular Access Device, a new long-
term dialysis access device approved by FDA for “access challenged” patients
i.e., catheter-dependent or patients that are poor candidates for fistulas or
grafts due to venous obstruction. TheHeRO™device is designed to provide
a graft-like vascular access and lower bacteremia rates than a tunneled dialysis
catheter.
Methods: The HeRO™ device, a graft with central outflow designed
to bypass peripheral stenosis, consists of an ePTFE upper arm graft fitted
with a titanium connector that is surgically coupled to a subcutaneous
nitinol reinforced silicone outflow catheter which exits into the right atrium
via the internal jugular vein. Procedural data has been captured on 60 early
commercialization patients implanted with the HeRO™ device including
access and medical history and device-implant success.
Results: To-date, data has been captured on 60 patients (mean age
58.9; 43.3% male; 55.0% diabetic) with a history of 4.1 years on dialysis, a
mean 5.0 previous catheters, 2.2 previous grafts, and 1.5 previous fistulas
and 3.6 mean previous bacteremias (range 1-17). The HeRO™ device was
successfully implanted in all subjects using a variety of interventional tech-
niques, although 60.0% percent had evidence of hemodynamically signifi-
cant central venous stenosis.
Conclusions: This data demonstrates that access-challenged patients
with challenging anatomy and central venous stenosis may be eligible for an
alternative long-term vascular access device offering lower bacteremia rates
compared to a tunneled dialysis catheter.
Author Disclosures: H.E. Katzman, Participating in HeRO commercial-
ization registry on behalf of Hemosphere, Inc and receiving nominal re-
search grant to complete case report forms as investigator in registry.
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Reduction and Reconstruction of Aneurysmal Arteriovenous Fistulas:
Mid-Term Results of a Novel Approach to Salvage Autogenous Dialysis
Access
Karen Woo1, Patrick R Cook1, Robert J Hye2, Timothy G Canty2. 1Scripps
Green Hospital, La Jolla, CA; 2Kaiser Permanente Medical Group, San
Diego, CA
Background: Over the last decade, K-DOQI guidelines have increas-
ingly emphasized the importance of autogenous arteriovenous fistulas
(AVF) for dialysis access. A complication of AVF is aneurysmal dilatation
with a subset developing massive diffuse aneurysm. Treatment of massive
aneurysmal AVF generally involves either ligation or resection with use of
prosthetic interposition. In order to maintain an all-autogenous access, we
developed a procedure to treat massive aneurysmal AVF in which the
lumenal diameter is reduced, excess length is resected, and the new recon-
structed AVF is retunneled for continued use.
Methods: Over a 4-year period, the reduction/revision procedure was
performed on 18 patients with an AVF diameter of 4-7cm. Indications for
operation were thrombosis, skin breakdown, infection, bleeding, and/or
poor flow. Revision was performed by resecting redundant length, reducing
diameter, and then reconstructing the fistula.
Results: Patients ranged in age from 25 to 83 with a mean of 48. There
were 12 men and 6 women. The mean and median follow-up was 20
months. The mean and median primary patency was 17 and 14 months,
respectively. The mean and median secondary patency was 19 and 16.5
months, respectively. Two patients died, one AVF thrombosed, and two
were ligated secondary to infection. One fistula developed a stenosis that was
treated with angioplasty. There are no recurrent aneurysms to date.
Conclusions: Surgical resection of excess length, reduction of lumenal
diameter, and reconstruction is a viable option for the treatment of compli-
cated massive diffusely aneurysmal AVF. This technique offers the ability to
maintain the benefits of an all autogenous dialysis access while conserving
future dialysis sites.Author Disclosures: K. Woo, None; P.R. Cook, None; R.J. Hye, None;
T.G. Canty, None.
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Report of the First Vascular Surgery in-Training Examination
(VSITE)
Amy B Reed1, Robert S Rhodes2, Thomas W Biester2, John J Ricotta3.
1University of Cincinnati, Cincinnati, OH; 2American Board of Surgery,
Philadelphia, PA; 3Washington Hospital Center, Washington, DC
Background: As Vascular surgery training has evolved from a single
clinical year following general surgery training to a multi year training
program with independent certification, the need for an in-training exami-
nation to assess the preparedness of the candidate for the certification
process has become apparent. Our objective is to analyze the psychometric
characteristics of the first Vascular Surgery In-Training Examination
(VSITE) and to correlate performance on the VSITE with performance on
the Qualifying Examination (QE) in Vascular Surgery.
Methods: The Vascular Surgery Board (VSB) in conjunction with the
Association of ProgramDirectors in Vascular Surgery (APDVS) appointed a
panel to develop the VSITE which was administered by the Vascular Surgery
Board of the American Board of Surgery(VSB/ABS). Thirty-one APDVS
and SVSmembers contributed questions in clinical and basic science areas of
vascular surgery training. All questions were again reviewed by the panel and
the VSB/ABS prior to administration of the examination. The psychometric
characteristics of the examination and correlation of performance on VSITE
and VQE were undertaken by ABS staff.
Results: On February 16, 2008, 240 examinees took the initial Vascu-
lar Surgery In-Training Examination online through a secure, proctored
website. This total included 216 vascular residents from 91 of 95 (96%)
training programs. The psychometric properties of the examination were
excellent with index values comparable to other ABS examinations. The
average difficulty value for all items was 76.6%, the average discrimination
value was 0.20, the total test reliability coefficient was 0.85 and the standard
error of measurement was 2.9% correct. Scores ranged from 55% to 93%
correct with an average of 76.7% correct. Sixty-four candidates took both the
VSITE and the VQE in 2008. A high correlation of 0.70 was noted between
